Becton Dickinson

Validation of core needle biopsy (CNB) devices currently relies on the use of fresh porcine tissue (shoulder, kidney, and connective tissue) which presents significant drawbacks for laboratory testing. Biological tissues inherently vary in mechanical properties and decay rapidly over time leading to inconsistent results, leaving room for improved test evaluation models. To address these challenges,…

Validation of core needle biopsy (CNB) devices currently relies on the use of fresh porcine tissue (shoulder, kidney, and connective tissue) which presents significant drawbacks for laboratory testing. Biological tissues inherently vary in mechanical properties and decay rapidly over time leading to inconsistent results, leaving room for improved test evaluation models. To address these challenges,…

Existing market solutions for breast lesion localization primarily rely on invasive devices, which can cause considerable patient discomfort and raise safety concerns among healthcare providers. These invasive options often require multiple clinic visits and involve procedures that are inconvenient and, sometimes, distressing for patients. Our solution proposes a non-invasive device that uses a controlled magnetic…

Current breast lesion localization methods, such as wire and radioactive seed placements, present several challenges—including patient discomfort, logistical complexity, and procedural risks. These invasive techniques often require pre-operative scheduling constraints, multiple clinic visits, and increased anxiety for patients. To address these limitations, our team has developed SONAR, a non-invasive breast lesion localization solution designed to…